DENVER, Sept. 25 /PRNewswire-FirstCall/ -- In the news release, Corgenix Reports Fiscal 2009 Financial Results, issued 25-Sep-2009 by Corgenix Medical Corporation (BULLETIN BOARD: CONX) over PR Newswire, the conference call replay phone numbers should read, "A replay will be available for 30 days following September 25th conference call by dialing (800)-283-9429 for domestic participants and +1 402-220-0871 for international participants."
Fiscal 2009 Conference Call Details
Corgenix invites all those interested in hearing management''s discussion of fiscal year results to join a shareholders conference call on Friday, September 25, 2009 at 4:00 PM EST (2:00 PM MST). Interested parties can join the call by dialing (800) 894-5910. International participants may access the call by dialing +1 785 424-1052. The conference code is "CORGENIX". A replay will be available for 30 days following September 25th conference call by dialing (800)-283-9429 for domestic participants and +1 402-220-0871 for international participants.
About Corgenix Medical Corporation
Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world''s only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA process. More information is available at http://www.corgenix.com/.
Statements in this press release that are not strictly historical facts are "forward looking" statements (identified by the words "believe", "estimate", "project", "expect" or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company''s products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company''s periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the company does not undertake any obligation to publicly update or revise any forward-looking statements.
Corgenix Medical Corporation
CONTACT: Company, William Critchfield, Senior VP and CFO of Corgenix
Medical Corp, +1-303-453-8903, wcritchfield@corgenix.com; or Media, Dan
Snyders, Vice President, Public Relations Supervisor of Armada Medical
Marketing, +1-303-623-1190, ext. 230, dan@armadamedical.com, for Corgenix
Medical Corp
Web Site: http://www.corgenix.com/
